Skip to main content
Divi's Laboratories Limited (NSE:DIVISLAB)
India flag India · Delayed Price · Currency is INR
6,329.00
-35.50 (-0.56%)
At close: Mar 6, 2026

Divi's Laboratories Revenue

Divi's Laboratories had revenue of 26.04B INR in the quarter ending December 31, 2025, with 12.29% growth. This brings the company's revenue in the last twelve months to 103.14B, up 13.62% year-over-year. In the fiscal year ending March 31, 2025, Divi's Laboratories had annual revenue of 93.60B with 19.31% growth.

Revenue (ttm)
103.14B
Revenue Growth
+13.62%
P/S Ratio
16.29
Revenue / Employee
9.78M
Employees
10,542
Market Cap
1,680.15B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 202593.60B15.15B19.31%
Mar 31, 202478.45B780.00M1.00%
Mar 31, 202377.67B-11.93B-13.31%
Mar 31, 202289.60B19.90B28.56%
Mar 31, 202169.69B15.75B29.20%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Cipla 279.67B
Zydus Lifesciences 260.89B
Mankind Pharma 139.14B
Aurobindo Pharma 331.82B
Sun Pharmaceutical Industries 568.09B
Alkem Laboratories 142.53B
Glenmark Pharmaceuticals 165.10B
Laurus Labs 67.22B
Revenue Rankings

Divi's Laboratories News

More News